MXPA02001297A - Derivados del fluoreno. - Google Patents

Derivados del fluoreno.

Info

Publication number
MXPA02001297A
MXPA02001297A MXPA02001297A MXPA02001297A MXPA02001297A MX PA02001297 A MXPA02001297 A MX PA02001297A MX PA02001297 A MXPA02001297 A MX PA02001297A MX PA02001297 A MXPA02001297 A MX PA02001297A MX PA02001297 A MXPA02001297 A MX PA02001297A
Authority
MX
Mexico
Prior art keywords
fluorene derivatives
disorders
arteriosclerosis
thrombosis
osteoporosis
Prior art date
Application number
MXPA02001297A
Other languages
English (en)
Spanish (es)
Inventor
St Hle Wolfgang
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA02001297A publication Critical patent/MXPA02001297A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02001297A 1999-08-07 2000-07-26 Derivados del fluoreno. MXPA02001297A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937394A DE19937394A1 (de) 1999-08-07 1999-08-07 Fluorenderivate
PCT/EP2000/007153 WO2001010841A2 (de) 1999-08-07 2000-07-26 Fluorenderivate als integrin inhibitoren

Publications (1)

Publication Number Publication Date
MXPA02001297A true MXPA02001297A (es) 2004-07-16

Family

ID=7917613

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02001297A MXPA02001297A (es) 1999-08-07 2000-07-26 Derivados del fluoreno.

Country Status (18)

Country Link
EP (1) EP1208088A2 (ja)
JP (1) JP2003506439A (ja)
KR (1) KR20020012631A (ja)
CN (1) CN1368962A (ja)
AR (1) AR025042A1 (ja)
AU (1) AU6828600A (ja)
BR (1) BR0013083A (ja)
CA (1) CA2380981A1 (ja)
CZ (1) CZ2002298A3 (ja)
DE (1) DE19937394A1 (ja)
HK (1) HK1049006A1 (ja)
HU (1) HUP0202464A3 (ja)
MX (1) MXPA02001297A (ja)
NO (1) NO20020592L (ja)
PL (1) PL353054A1 (ja)
SK (1) SK1402002A3 (ja)
WO (1) WO2001010841A2 (ja)
ZA (1) ZA200201873B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102808B1 (ko) * 2010-04-13 2012-01-05 윤태삼 라이저 인장 장치
US8574899B2 (en) 2010-12-22 2013-11-05 Vladimir B Serikov Methods for augmentation collection of placental hematopoietic stem cells and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058925A1 (en) * 1989-06-22 1990-12-23 Moshe Weitzberg Pharmaceutical compositions and methods for treating inflammation
IL113196A0 (en) * 1994-03-31 1995-06-29 Bristol Myers Squibb Co Imidazole derivatives and pharmaceutical compositions containing the same
ES2162676T3 (es) * 1996-03-29 2002-01-01 Searle & Co Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
DE19654483A1 (de) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanin-Derivate
CA2214931A1 (en) * 1996-09-26 1998-03-26 Henry Uhlman Bryant Tetrahydrobenzo-a-fluorene compounds and method of use

Also Published As

Publication number Publication date
HUP0202464A3 (en) 2003-02-28
HK1049006A1 (zh) 2003-04-25
AR025042A1 (es) 2002-11-06
CA2380981A1 (en) 2001-02-15
KR20020012631A (ko) 2002-02-16
BR0013083A (pt) 2002-04-23
WO2001010841A2 (de) 2001-02-15
JP2003506439A (ja) 2003-02-18
NO20020592L (no) 2002-04-04
CZ2002298A3 (cs) 2002-04-17
PL353054A1 (en) 2003-10-06
DE19937394A1 (de) 2001-02-08
SK1402002A3 (en) 2002-06-04
HUP0202464A2 (hu) 2002-12-28
NO20020592D0 (no) 2002-02-06
AU6828600A (en) 2001-03-05
WO2001010841A3 (de) 2001-09-07
CN1368962A (zh) 2002-09-11
ZA200201873B (en) 2003-08-27
EP1208088A2 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
TW372232B (en) Phenylalanine derivatives
NO20010203L (no) Diacylhydrazinderivater som integrininhibitorer
NO986090L (no) Fenylalaninderivater som integrininhibitorer
NZ511927A (en) Phenylglycine derivatives
MY134783A (en) Rho-kinase inhibitors
MY142915A (en) Rho-kinase inhibitors
DE60324183D1 (en) Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
CA2280727A1 (en) Bicyclic amino acids
DK1259485T3 (da) Benzamider og beslægtede inhibitorer for faktor Xa
FI913478A0 (fi) Diazinderivat.
ATE303359T1 (de) Biphenylverbindungen und biphenyl-analoge als intergrin-antagonisten
WO2002057261A3 (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
AU3864500A (en) Substituted aza-oxindole derivatives
DK0939627T3 (da) Pentaflourbenzensulfonamider og analoger
MY133897A (en) N-(4-carb-amimidophenyl) glycineamide derivatives
CA2348391A1 (en) Chromenone and chromanone derivatives as integrin inhibitors
CY1107149T1 (el) Νεα παραγωγα αμιδινοβενζυλαμινης και χρηση τους ως αναστολεων θρομβινης
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
WO2000048996A3 (de) Beta-alaninderivate
NO20032754D0 (no) Urea- og/eller uretanderivater som integrininhibitorer
NO20020131L (no) Diacylhydrazinderivater
MXPA02001297A (es) Derivados del fluoreno.
MXPA03010205A (es) Derivados de acido oxalico.
NO20000016L (no) Sykliske azapeptider med angiogen virkning

Legal Events

Date Code Title Description
FA Abandonment or withdrawal